|Bid||0.0000 x 4000|
|Ask||0.0000 x 1800|
|Day's range||3.8600 - 4.0750|
|52-week range||3.4200 - 11.1000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||28 Feb 2022 - 04 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||12.50|
Insiders who bought Precigen, Inc. ( NASDAQ:PGEN ) stock in the last 12 months were richly rewarded last week. The...
Investors need to pay close attention to Precigen (PGEN) stock based on the movements in the options market lately.
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in the Stifel 2021 Virtual Healthcare Conference on Wednesday, November 17, 2021 at 10:40 AM ET.